RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in RAPT Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 91
- −3 vs. Q3 2024
- Shares held
- 126.9M
- +97.1M (+325.8%) vs. Q3 2024
- Total value
- $199.5M
- +$139.6M (+233.0%) vs. Q3 2024
- New holders
- 29
- 31 more added
- Sold out
- 32
- 20 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RAPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 106 | $1.02B |
| Q3 2025 | 65 | $428.0M |
| Q2 2025 | 50 | $135.6M |
| Q1 2025 | 92 | $160.0M |
| Q4 2024 | 91 | $199.5M |
| Q3 2024 | 94 | $59.9M |
| Q2 2024 | 103 | $97.0M |
| Q1 2024 | 122 | $287.2M |
| Q4 2023 | 109 | $869.3M |
| Q3 2023 | 96 | $577.8M |
| Q2 2023 | 98 | $636.7M |
| Q1 2023 | 106 | $610.5M |
| Q4 2022 | 95 | $634.7M |
| Q3 2022 | 98 | $721.0M |
| Q2 2022 | 85 | $542.7M |
| Q1 2022 | 85 | $616.1M |
| Q4 2021 | 99 | $1.02B |
| Q3 2021 | 106 | $817.8M |
| Q2 2021 | 109 | $846.6M |
| Q1 2021 | 78 | $468.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding RAPT Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nomura Holdings Inc | 0 | $0 | 0.00% | −84,184−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −71,449−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −55,520−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −53,645−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −45,050−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −37,955−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −36,998−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −25,325−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −25,144−100.0% | Sold out |
| Quinn Opportunity Partners LLC | 0 | $0 | 0.00% | −14,409−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −14,400−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −12,262−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −10,450−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −6,713−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −3,288−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,217−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −1,262−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −959−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −629−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −101−100.0% | Sold out |